Brenda S. Furlow has joined Bio-Techne as senior vice president and general counsel, where she is responsible for legal and compliance matters for the company and its affiliates.

Her recent experience includes several years as general counsel of a publicly traded medical devices company and, prior to that, almost ten years as general counsel with Promega, a private life sciences company. Furlow brings extensive experience in the areas of intellectual property, patent and licensing, compliance, litigation and regulatory.

“We are very pleased to welcome Ms. Furlow to our executive team and company,” said Charles Kummeth, president/CEO of Bio-Techne in a statement. “Her background is perfectly aligned with our business and our strategic direction; her experience will be essential as we expand our global and platform footprint.”

Furlow earned her J.D. from the University of Chicago and a Bachelor of Arts from Calvin College